Study of CETN1: Potential Drug Target and Biomarker (G1068)

Target Name: CETN1

NCBI ID: G1068

CETN1

Study of CETN1: Potential Drug Target and Biomarker

CETN1, or Calbindin Extracellular Tissue Network 1, is a protein that is expressed in a variety of tissues throughout the body, including the brain, pancreas, and muscle. It is a member of the Calbindin family of proteins, which are known for their ability to bind to and stimulate the activity of various cellular signaling molecules.

One of the things that makes CETN1 an interesting potential drug target is its role in a variety of biological processes. For example, it has been shown to be involved in the regulation of cell division, differentiation, and migration. It has also been shown to play a role in the development and progression of a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential drug-targeting properties, CETN1 is also a potential biomarker. Its expression has been shown to be associated with a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This makes it a promising candidate for use as a diagnostic or monitoring tool in these cases.

One of the challenges in studying CETN1 is its complex structure and the fact that it is expressed in a variety of tissues. This makes it difficult to study its effects in a controlled and precise manner. However, researchers have been able to use a variety of techniques to study its behavior, including cell-based assays, in vitro assays, and animal models.

In addition to its potential drug and biomarker applications, CETN1 is also of interest to researchers because of its ability to regulate cell division and differentiation. This makes it a potential target for drugs that are designed to promote or inhibit these processes. For example, drugs that have been shown to inhibit the activity of CETN1 have been shown to have potential therapeutic applications in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Overall, CETN1 is a protein that is of great interest to researchers due to its complex structure and the variety of biological processes it is involved in. Its potential as a drug target and biomarker make it a promising candidate for further study.

Protein Name: Centrin 1

Functions: Plays a fundamental role in microtubule-organizing center structure and function (PubMed:8175926). Plays a role in sperm cilia formation (By similarity)

The "CETN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CETN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets